In Erbin deficiency BMDMs, we found lower levels of CTSB and LAMP2, as well as a more serious disrupted lysosome acidic environment, than the MDP-treated WT BMDMs. This evidence concerns the gene CTSB and hyperinsulinemic hypoglycemia, familial, 4.